Abstract

DREAM (calsenilin/KChIP3) is an EF-hand calcium-binding protein that represses transcription of prodynorphin and c-fos genes. Here we present structural and binding studies on single-site mutants of DREAM designed to disable Ca(2+) binding to each of the functional EF-hands (EF-2: D150N; EF-3: E186Q; and EF-4: E234Q). Isothermal titration calorimetry (ITC) analysis of Ca(2+) binding to the various mutants revealed that, in the absence of Mg(2+), Ca(2+) binds independently and sequentially to EF-3 (DeltaH = -2.4 kcal/mol), EF-4 (DeltaH = +5.2 kcal/mol), and EF-2 (DeltaH = +1 kcal/mol). By contrast, only two Ca(2+) bind to DREAM in the presence of physiological levels of Mg(2+) for both wild-type and D150N, suggesting that EF-2 binds constitutively to Mg(2+). ITC measurements demonstrate that one Mg(2+) binds enthalpically with high affinity (K(d) = 13 mum and DeltaH = -0.79 kcal/mol) and two or more Mg(2+) bind entropically in the millimolar range. Size-exclusion chromatography studies revealed that Mg(2+) stabilizes DREAM as a monomer, whereas Ca(2+) induces protein dimerization. Electrophoretic mobility shift assays indicated that Mg(2+) is essential for sequence-specific binding of DREAM to DNA response elements (DREs) in prodynorphin and c-fos genes. The EF-hand mutants bind specifically to DRE, suggesting they are functionally intact. None of the EF-hand mutants bind DRE at saturating Ca(2+) levels, suggesting that binding of a single Ca(2+) at either EF-3 or EF-4 is sufficient to drive conformational changes that abolish DNA binding. NMR structural analysis indicates that metal-free DREAM adopts a folded yet flexible molten globule-like structure. Both Ca(2+) and Mg(2+) induce distinct conformational changes, which stabilize tertiary structure of DREAM. We propose that Mg(2+) binding at EF-2 may structurally bridge DREAM to DNA targets and that Ca(2+)-induced protein dimerization disrupts DNA binding.

Highlights

  • EF-hand Ca2ϩ-binding protein that serves as a transcriptional repressor for pain modulation [3,4,5]

  • We present a structural analysis of Mg2ϩ and Ca2ϩ ment antagonist modulator; DREAM-C, deletion mutant of mouse DREAM consisting of residues 65–256; apoDREAM-C, metal-free DREAM; Mg2ϩ-DREAM-C, Mg2ϩ-bound DREAM; Ca2ϩ-DREAM-C, Ca2ϩ-bound DREAM; HSQC, heteronuclear single quantum coherence; Isothermal titration calorimetry (ITC), isothermal titration calorimetry; KChIP, potassium channel-interacting protein; size-exclusion chromatography (SEC), size exclusion chromatography; Electrophoresis mobility shift assays (EMSA), electrophoretic mobility-shift analysis; NOE, nuclear Overhauser effect; NOESY, NOE spectroscopy

  • The results reveal that Mg2ϩ is required for sequence-specific DNA binding; Mg2ϩ binds constitutively at EF-2; Mg2ϩ stabilizes a monomeric form of DREAM; Ca2ϩ induces protein dimerization; and Ca2ϩ binding at either EF-3 or EF-4 is sufficient to abolish DNA binding at high Ca2ϩ

Read more

Summary

Introduction

EF-hand Ca2ϩ-binding protein that serves as a transcriptional repressor for pain modulation [3,4,5]. The ITC isotherm of D150N exhibits stoichiometric binding of two Ca2ϩ ions but lacks the low affinity endothermic phase seen in wild-type, suggesting that EF-2 is the low affinity site.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.